Galapagos NV ADR (GLPG): Next-Year EPS Estimate 26.01%
As of 2026-04-28, Galapagos NV ADR (GLPG) has a next-year EPS growth estimate of 26.01%.
On 2026-04-06, analyst consensus for GLPG's next-year EPS growth shifted from 27.94% to 26.01% — a negative change of 1.93 percentage points. The revised estimate has been sustained across 19 subsequent trading sessions. Current-year growth is projected at -142.87%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 26.01%
- EPS growth this year
- -142.87%
- EPS next quarter (est)
- -$0.94
- Last price
- $28.42
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-04-28 | 26.01% | -142.87% | -$0.94 | $28.42 |
| 2026-04-27 | 26.01% | -142.87% | -$0.94 | $28.47 |
| 2026-04-26 | 26.01% | -142.87% | -$0.94 | $28.60 |
| 2026-04-24 | 26.01% | -142.87% | -$0.94 | $28.60 |
| 2026-04-23 | 26.01% | -142.87% | -$0.94 | $28.68 |
| 2026-04-22 | 26.01% | -142.87% | -$0.94 | $29.14 |
| 2026-04-21 | 26.01% | -142.87% | -$0.94 | $28.91 |
| 2026-04-20 | 26.01% | -142.87% | -$0.94 | $29.28 |
| 2026-04-19 | 26.01% | -142.87% | -$0.94 | $29.28 |
| 2026-04-16 | 26.01% | -142.87% | -$0.94 | $28.86 |
| 2026-04-15 | 26.01% | -142.87% | -$0.94 | $29.16 |
| 2026-04-14 | 26.01% | -142.87% | -$0.94 | $28.88 |
| 2026-04-13 | 26.01% | -142.87% | -$0.94 | $28.56 |
| 2026-04-12 | 26.01% | -142.87% | -$0.94 | $28.40 |
| 2026-04-10 | 26.01% | -142.87% | -$0.94 | $28.54 |
| 2026-04-09 | 26.01% | -142.87% | -$0.94 | $28.56 |
| 2026-04-08 | 26.01% | N/A | -$0.94 | $28.89 |
| 2026-04-07 | 26.01% | N/A | -$0.94 | $28.93 |
| 2026-04-06 | 26.01% | N/A | -$0.94 | $28.93 |
| 2026-04-05 | 27.94% | N/A | -$0.95 | $29.42 |
| 2026-04-03 | 26.01% | N/A | -$0.94 | $28.93 |
| 2026-04-02 | 26.01% | N/A | -$0.94 | $28.93 |
| 2026-04-01 | 26.01% | N/A | -$0.94 | $28.93 |
| 2026-04-01 | 58.24% | N/A | N/A | $30.00 |
| 2026-04-01 | 27.94% | N/A | N/A | $29.76 |
| 2026-04-01 | 27.94% | N/A | N/A | $29.76 |
| 2026-03-31 | 41.33% | N/A | N/A | $28.84 |
| 2026-03-31 | 41.35% | N/A | N/A | $30.00 |
| 2026-03-31 | 41.35% | N/A | N/A | $30.00 |
| 2026-03-30 | 41.33% | N/A | N/A | $28.93 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Galapagos NV ADR's next-year EPS growth estimate?▾
As of 2026-04-28, Galapagos NV ADR (GLPG) has a next-year EPS growth estimate of 26.01%, based on analyst consensus.
When was the latest EPS estimate revision for GLPG?▾
The most recent revision occurred on 2026-04-06, when analysts adjusted the next-year EPS growth estimate from 27.94% to 26.01%.
What sector and industry does Galapagos NV ADR belong to?▾
Galapagos NV ADR operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. GLPG appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Galapagos NV ADR (GLPG) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports